- $892.46m
- $1.90bn
- $1.60bn
- 65
- 95
- 65
- 88
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,418 | 1,426 | 1,487 | 1,496 | 1,601 |
Cost of Revenue | |||||
Gross Profit | 909 | 892 | 887 | 882 | 938 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,366 | 1,407 | 1,797 | 3,357 | 1,432 |
Operating Profit | 51.8 | 19.7 | -310 | -1,860 | 169 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -127 | -186 | -195 | -1,915 | 20.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -110 | -127 | -110 | -1,862 | -20.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -110 | -127 | -111 | -1,863 | -20.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -110 | -127 | -111 | -1,863 | -20.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.17 | -3.55 | 2.37 | -9.93 | -0.362 |
Dividends per Share |